An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance

Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review

60 Scopus Citations
Scopus Metrics
View graph of relations

Author(s)

Related Research Unit(s)

Detail(s)

Original languageEnglish
Pages (from-to)13052-13060
Journal / PublicationDalton Transactions
Volume45
Issue number33
Online published5 Jul 2016
Publication statusPublished - 7 Sept 2016

Link(s)

DOI

DOI
Check@CityULib
Link to Scopus https://www.scopus.com/record/display.uri?eid=2-s2.0-84983350348&origin=recordpage
Permanent Link https://scholars.cityu.edu.hk/en/publications/publication(ac838684-6544-4ac5-8d7d-445650bd398f).html

Abstract

Platinum-based antineoplastic drugs are among the first-line chemotherapeutic agents against a variety of solid tumors, but toxic side-effects and drug resistance issues limit their clinical optimization. Novel strategies and platforms to conquer cisplatin resistance are highly desired. Herein, we assembled a multimodal nanoplatform utilizing 808 nm-excited and biocompatible core-shell-shell upconversion nanoparticles (UCNPs) [NaGdF4:Yb/Nd

Research Area(s)

Fingerprint

Publication fingerprints text

100
shells INIS
100
chemotherapy INIS
100
photodynamic therap... INIS
100
Upconversion Keyphrases
100
Chemotherapy Keyphrases
100
Photodynamic Therap... Keyphrases
100
Nanoplatform Keyphrases
100
Cisplatin Resistanc... Keyphrases
100
Nanoparticle Chemical Engineering
100
Platinum Chemical Engineering
Full Fingerprint ›

Citation Format(s)

[ RIS ] [ BibTeX ]
An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance. / Ai, Fujin; Sun, Tianying; Xu, Zoufeng et al.
In: Dalton Transactions, Vol. 45, No. 33, 07.09.2016, p. 13052-13060.

Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review